stockrow
Friday 6 November 2026
Export IRON’s income statement to Excel — free account
Disc Medicine, Inc.
IRON Healthcare Biotechnology
- EPS
- +2.53%
- Free cash flow
- +7.83%
- Total debt
- +106.5%
Quarter to June 2026, against a year earlier
78.51
0.04
+0.05%
Follow IRON
Alert me
Disc Medicine, Inc. (IRON) Total debt
Disc Medicine, Inc.'s total debt at the end of fiscal 2025 was $29.2M, unchanged from fiscal 2024. At the end of the quarter to 30 June 2026 it was $59.3M. Over the past ten years it has ranged from $404.0K (fiscal 2021) to $29.2M (fiscal 2025) — the current reading is the highest in ten years. Disc Medicine, Inc. ranks 122nd of 569 Biotechnology companies by total debt.
Total debt, annual
Embed this chart
Annual newest first
| Period | Total debt | Change |
|---|---|---|
| FY2025 | $29.2M | 2.96% |
| FY2024 | $28.3M | 2,657.74% |
| FY2022 | $1.0M | 154.21% |
| FY2021 | $404.0K | (69.72%) |
| FY2021 | $1.3M | (86.59%) |
| FY2020 | $10.0M | (54.02%) |
| FY2020 | $21.6M | — |
Quarterly newest first
| Period | Total debt | Change |
|---|---|---|
| Jun 2026 | $59.3M | 102.08% |
| Mar 2026 | $29.4M | 0.71% |
| Dec 2025 | $29.2M | 0.73% |
| Sep 2025 | $28.9M | 0.73% |
| 14 more quarters | Free account |
Against its own ten years
Low $404.0K
High $29.2M
Ten-year median
$10.0M
Current reading's percentile
100
Total debt against peers
| Company | Total debt |
|---|---|
| VKTX Viking Therapeutics, Inc. compare | $250.7M |
| DYN Dyne Therapeutics, Inc. compare | $213.5M |
| IRON Disc Medicine, Inc. | $59.3M |
| RLAY Relay Therapeutics, Inc. compare | $55.0M |
| ACAD ACADIA Pharmaceuticals Inc. compare | $48.1M |
| TNGX Tango Therapeutics, Inc. compare | $39.5M |
| XENE Xenon Pharmaceuticals Inc. compare | $11.0M |
| PBLS Parabilis Medicines, Inc. compare | $6.8M |
| IOVA Iovance Biotherapeutics, Inc. compare | $1.0M |
What Total debt is
Total Debt tells an investor how much a company has borrowed in all, whether the money is due within a year or later.
Long Term Debt (Total) + Current Part of Debt